Literature DB >> 12523575

Umbilical cord blood transplantation: where do we stand?

Raymond C Wadlow1, David L Porter.   

Abstract

Although allogeneic stem cell transplantation can cure patients with hematologic malignancies, limiting factors such as lack of suitable donors and GVHD toxicity have led to the exploration of umbilical cord blood (UCB) as an alternative source of hematopoietic stem cells. This overview examines the advantages and disadvantages of UCB as a donor source and reviews data from preclinical and clinical studies. Ethical issues regarding UCB transplantation are also addressed.

Entities:  

Mesh：

Year:  2002        PMID： 12523575     DOI： 10.1053/bbmt.2002.v8.abbmt080637

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  6 in total

1.  Posttransplantation engraftment and safety of cord blood transplantation with grafts containing relatively low cell doses in adults.

Authors:  Satoshi Takahashi; Jun Ooi; Akira Tomonari; Takaaki Konuma; Nobuhiro Tsukada; Arinobu Tojo; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

2.  Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank.

Authors:  Jinhui Liu; Ji He; Shu Chen; Fei Qin; Fang Wang; Gang Xu; Faming Zhu; Hangjun Lv; Lixing Yan
Journal:  Transfus Med Hemother       Date:  2011-12-27       Impact factor: 3.747

3.  Pre-birth selection of umbilical cord blood donors.

Authors:  Patrizia Urciuoli; Simona Passeri; Francesca Ceccarelli; Barbara Luchetti; Aldo Paolicchi; Simone Lapi; Francesca Nocchi; Roberta Lamanna; Mariacarla Iorio; Renato Vanacore; Alessandro Mazzoni; Fabrizio Scatena
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

4.  Four phases of checks for exclusion of umbilical cord blood donors.

Authors:  Gennaro Volpe; Michele Santodirocco; Lazzaro Di Mauro; Giuseppe Miscio; Filippo Maria Boscia; Brunella Muto; Nicola Volpe
Journal:  Blood Transfus       Date:  2011-04-07       Impact factor: 3.443

5.  Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.

Authors:  Federico Moscardó; Jaime Sanz; Leonor Senent; Susana Cantero; Javier de la Rubia; Pau Montesinos; Dolores Planelles; Ignacio Lorenzo; Jose Cervera; Javier Palau; Miguel A Sanz; Guillermo F Sanz
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

6.  Isolation and morphological characterization of ovine amniotic fluid mesenchymal stem cells.

Authors:  Yunyun Tian; Li Tao; Siriguleng Zhao; Dapeng Tai; Dongjun Liu; Pengxia Liu
Journal:  Exp Anim       Date:  2015-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.